<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01302470</url>
  </required_header>
  <id_info>
    <org_study_id>04-052</org_study_id>
    <nct_id>NCT01302470</nct_id>
  </id_info>
  <brief_title>Comparison of Epicardial Versus Conventional Lead Placement in Cardiac Resynchronization Therapy</brief_title>
  <acronym>REVERT</acronym>
  <official_title>Randomized Study of Endovascular Versus Epicardial Lead Placement for Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's-Roosevelt Hospital Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Luke's-Roosevelt Hospital Center</source>
  <brief_summary>
    <textblock>
      The primary goal of this study is to evaluate the use of robotically -assisted device leads
      as a primary strategy for heart resynchronization.This trials aims to compare transvenous
      lead placement with robotic lead placement for cardiac resynchronization therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A secondary goal is to explore the link between efficacy of CRT and inotropic contractile
      reserve as measured by dobutamine stress echocardiography.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CHF Hospitalizations &amp; mortality</measure>
    <time_frame>one year post implant.</time_frame>
    <description>Heart failure and mortality will be assesd along with six minute hall walk tests</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cardiac Resynchronization Therapy</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Robotic placement of CS lead</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CS leads placed epicardially in the area of increased dyssynchrony as demonstrated by low dose dobutamine stress testing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transvenous placement of CS lead</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CS lead will be placed transvenously</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Primary epicardial placement of left ventricular lead</intervention_name>
    <description>Epicardial leads will be placed on the left ventricle in the area of the most dyssynchrony . the leads will be attached to a Medtronic Cardiac resynchronization/ AICD/ device</description>
    <arm_group_label>Robotic placement of CS lead</arm_group_label>
    <other_name>cardiac resynchronization therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvenous placement of left ventricular lead</intervention_name>
    <description>Conventional placement of left ventricular leads performed in the electrophysiology department.</description>
    <arm_group_label>Transvenous placement of CS lead</arm_group_label>
    <other_name>Cardiac resynchronization Therapy</other_name>
    <other_name>CRT/ AICD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic NYHA class III or IV heart failure from idiopathic or ischemic heart
             failure

          -  QRS interval greater than or equal to 130 msec

          -  Left ventricular end diastolic diameter greater than or equal to 55 mm

          -  left ventricular ejection fraction less than or equal to 35

          -  Willingness to participate

        Exclusion Criteria:

          -  Acute renal failure; active GI bleeding; unexplained fever which may be due to an
             infection

          -  untreated active infection

          -  acute stroke

          -  severe uncontrolled systemic hypertension

          -  severe systemic electrolyte imbalance

          -  severe concomitant illness that drastically shortens life expectancy

          -  severe coagulopathy

          -  history of severe COPD and inability to tolerate single lung ventilation

          -  History of prior left sided thoracotomy

          -  history of recent intravenous drug use

          -  concomitant psychiatric diagnosis that impairs patient's ability to comply with study
             protocol

          -  participation in another investigational protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St.Lukes-Roosevelt Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2011</study_first_posted>
  <last_update_submitted>February 18, 2015</last_update_submitted>
  <last_update_submitted_qc>February 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biventricular pacing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

